Stay updated with breaking news from Brian Markison. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
2022 includes $15,500 in licensing revenue recognized in connection with an amendment of our License Agreement with Santen, effective March 31, 2022, net of a $500 transaction fee expense classified... | May 11, 2023
[Bridgewater, NJ] (PRWEB) March 31, 2023 -- RVL Pharmaceuticals announced today that its prescription eye drop Upneeq® (oxymetazoline hydrochloride ophthalmic
03.04.2023 - Selected from 10,000 EntrantsBRIDGEWATER, N.J., April 03, 2023 (GLOBE NEWSWIRE) - RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”) announced today that its prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic ... Seite 1
[Bridgewater, NJ] (PRWEB) March 31, 2023 -- RVL Pharmaceuticals announced today that its prescription eye drop Upneeq® (oxymetazoline hydrochloride ophthalmic
20.03.2023 - - RVLP records exceptional year-over-year growth with UPNEEQ launch into the medical aesthetics market - - Full year 2022 total revenues of $49.7 million, an increase of $32.2 million, or 184%, over 2021 - - Full year 2022 UPNEEQ net product sales ...